LEONARD JOHN M

CIK 00015635845 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001563584

Recent Transactions

50 trades

Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2026-01-05$9.21/sh−34,146→ 1,013,339 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2025-12-12−8,557→ 0 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Common Stock
2025-12-12$6.83/sh+8,557→ 1,047,485 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2025-12-11−49,959→ 8,557 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Common Stock
2025-12-11$6.83/sh+49,959→ 1,127,074 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2025-12-11$9.59/sh−5,355→ 1,038,928 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2025-12-11$9.47/sh−32,832→ 1,044,283 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2025-12-11$9.49/sh−49,959→ 1,077,115 total
Award
IQVIA HOLDINGS INC.$IQV
Common Stock
2025-04-24+1,592→ 15,375 total
Award
Intellia Therapeutics, Inc.$NTLA
Common Stock
2025-03-01+136,000→ 1,077,115 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2025-03-01+196,000→ 196,000 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2025-01-03$12.18/sh−26,807→ 941,115 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Common Stock
2025-01-01+7,850→ 967,922 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Restricted Stock Unit
2025-01-01−7,850→ 0 total
Award
IQVIA HOLDINGS INC.$IQV
Common Stock
2024-05-07+1,047→ 13,783 total
Award
Intellia Therapeutics, Inc.$NTLA
Common Stock
2024-03-01+113,586→ 960,072 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2024-03-01+163,929→ 163,929 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2024-01-03$29.46/sh−19,223→ 846,486 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Restricted Stock Unit
2024-01-01−7,848→ 7,850 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Common Stock
2024-01-01+7,848→ 865,709 total
Award
IQVIA HOLDINGS INC.$IQV
Common Stock
2023-05-10+1,063→ 12,736 total
Award
Intellia Therapeutics, Inc.$NTLA
Common Stock
2023-03-01+91,036→ 857,861 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2023-03-01+128,631→ 128,631 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2023-01-04$37.21/sh−6,673→ 766,825 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Common Stock
2023-01-01+7,848→ 773,498 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Restricted Stock Unit
2023-01-01−7,848→ 15,698 total
Award
IQVIA HOLDINGS INC.$IQV
Common Stock
2022-05-11+995→ 11,673 total
Award
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2022-03-01+59,941→ 59,941 total
Award
Intellia Therapeutics, Inc.$NTLA
Common Stock
2022-03-01+40,990→ 765,650 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Restricted Stock Unit
2022-01-01−7,848→ 23,546 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2022-01-01$112.25/sh−2,493→ 724,660 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Common Stock
2022-01-01+7,848→ 727,153 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2021-09-01−28,750→ 0 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-09-01$18.30/sh+15,985→ 764,040 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2021-09-01−15,985→ 11,515 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-09-01$170.00/sh−44,735→ 719,305 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-09-01$23.46/sh+28,750→ 748,055 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2021-08-31−37,833→ 90,000 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-08-31$155.00/sh−37,833→ 719,305 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-08-31$14.58/sh+37,833→ 757,138 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-08-30$157.75/sh−3,123→ 722,844 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-08-30$155.70/sh−15,567→ 730,725 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-08-30$13.40/sh+11,637→ 730,942 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-08-30$152.81/sh−2,055→ 756,054 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-08-30$14.58/sh+27,167→ 758,109 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-08-30$160.69/sh−216→ 719,305 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2021-08-30−11,637→ 212,501 total
Exercise/Conversion
Intellia Therapeutics, Inc.$NTLA
Stock Option (right to buy)
2021-08-30−27,167→ 127,833 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-08-30$159.98/sh−725→ 719,521 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2021-08-30$153.66/sh−2,334→ 753,720 total

Companies

Recent Filings

Address

C/O INTELLIA THERAPEUTICS, INC. 40 ERIE STREET; SUITE 130

CAMBRIDGE, MA, 02139

View on SEC.gov